CoChat

Prevalence of GH and other anterior pituitary hormone deficiencies in adults with nonsecreting pituitary microadenomas and normal serum IGF‐1 levels

Open access
Yuen, Kevin C. J., Cook, David M., Sahasranam, Prem, Patel, Pragnesh, Ghods, David E., Shahinian, Hrayr K., Friedman, Theodore C. · 2008 · Clinical Endocrinology
Cited by 53

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Summary: Objective GH is usually the first pituitary hormone to be affected following a pathological insult to the pituitary; however, data on the prevalence of GH deficiency in patients with nonsecreting pituitary microadenomas and normal serum IGF‐1 levels are scarce. This study aims to evaluate the prevalence of GH and other anterior pituitary hormone deficiencies, and to determine whether microadenomas per se could be associated with reduced GH response rates to GHRH–arginine stimulation. Design Analytical, retrospective, two‐site case‐control study. Patients and methods Thirty‐eight patients with nonsecreting pituitary microadenomas (mean size 4·2 mm) and normal serum IGF‐1 levels were studied. Anterior pituitary function testing, including the GHRH–arginine test to examine GH reserve, was performed in all patients. Serum IGF‐1 levels and peak GH levels in the patients that passed the GHRH–arginine test were compared with 22 age‐ and BMI‐matched healthy controls. Results Nineteen patients (50%) failed the GHRH–arginine test and had higher body mass index (BMI) than those that passed the GHRH–arginine test and healthy controls. Peak GH levels in patients that passed the GHRH–arginine test were lower compared to healthy controls and 19 patients (50%) had at least one other pituitary hormone deficit. A negative correlation (r = –0·42, P < 0·01) between peak GH levels and BMI was identified, but no correlations were found between peak GH and serum IGF‐1 levels. Conclusions Our data demonstrated that a substantial number of patients with nonsecreting pituitary microadenomas failed the GHRH–arginine test despite normal serum IGF‐1 levels, and had at least one other pituitary hormone deficiency, suggesting that nonsecreting microadenomas may not be clinically harmless. We therefore recommend long‐term follow‐up with periodic basal pituitary function testing, and to consider dynamic pituitary testing should clinical symptoms arise in these patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2008.03201.x

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 53

Metadata

Authors
Yuen, K. C. J., Cook, D. M., Sahasranam, P., Patel, P., Ghods, D. E., Shahinian, H. K., & Friedman, T. C.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2008-07-15
Volume
69
Issue
2
Pages
292-298
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2115377410
Cited by
53
References
11
FWCI
1.31
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence of GH and other anterior pituitary hormone deficiencies in adults with nonsecreting pituitary microadenomas and normal serum IGF‐1 levels. https://app.cochat.ai/papers/10.1111/j.1365-2265.2008.03201.x
The paper
Yuen, K. C. J., Cook, D. M., Sahasranam, P., Patel, P., Ghods, D. E., Shahinian, H. K., & Friedman, T. C. (2008). Prevalence of GH and other anterior pituitary hormone deficiencies in adults with nonsecreting pituitary microadenomas and normal serum IGF‐1 levels. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2008.03201.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.